Delaware Judge Tosses Biotech Exec.'s $700M Suit Over Failed IPO

A Delaware judge dismissed a former Aurion Biotech executive's challenge to a stockholder's alleged takeover of the company, finding he failed to plausibly allege that defendants caused the abandonment of the planned IPO.